Clinical Trial Update: Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

View source ↗

Summary

A completed pilot pharmacokinetic study evaluated adalimumab trough concentrations in Crohn's disease to characterize drug exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Crohn's Disease | Status: COMPLETED